Sellas Life Sciences Group Inc (SLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2020 | 12-2019 | 09-2019 | 06-2019 | 03-2019 | |
| Operating Expenses | 4,064 | 7,479 | 4,184 | 4,019 | 4,359 |
| Operating Income | -4,064 | -7,479 | -4,184 | -4,019 | -4,359 |
| Other Income | -79 | -21 | -18 | 885 | -178 |
| Pre-tax Income | -4,143 | -7,500 | -4,202 | -3,134 | -4,537 |
| Net Income Continuous | -4,143 | -7,419 | -4,202 | -3,134 | -4,537 |
| Net Income | $-4,143 | $-7,419 | $-4,202 | $-3,134 | $-4,537 |
| EPS Basic Total Ops | -0.66 | 9.21 | -2.68 | -6.33 | -11.12 |
| EPS Basic Continuous Ops | -0.65 | 8.44 | -0.98 | -4.85 | -10.15 |
| EPS Diluted Total Ops | -0.66 | 9.21 | -2.68 | -6.33 | -11.12 |
| EPS Diluted Continuous Ops | -0.65 | 8.44 | -0.98 | -4.85 | -10.15 |
| EBITDA(a) | $-4,064 | $-7,479 | $-4,184 | $-4,019 | $-4,359 |